Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
GlaxoSmithKline plc
Index- P/E16.36 EPS (ttm)2.76 Insider Own- Shs Outstand2.40B Perf Week-0.49%
Market Cap108.47B Forward P/E14.51 EPS next Y3.11 Insider Trans- Shs Float2.39B Perf Month-1.66%
Income6.73B PEG5.45 EPS next Q0.45 Inst Own11.10% Short Float0.26% Perf Quarter-4.75%
Sales38.17B P/S2.84 EPS this Y22.50% Inst Trans-0.73% Short Ratio1.20 Perf Half Y-16.05%
Book/sh3.36 P/B13.43 EPS next Y3.32% ROA10.40% Target Price50.00 Perf Year-9.70%
Cash/sh2.78 P/C16.22 EPS next 5Y3.00% ROE67.60% 52W Range41.91 - 55.21 Perf YTD-12.14%
Dividend2.59 P/FCF- EPS past 5Y4.70% ROI24.90% 52W High-17.62% Beta0.63
Dividend %5.74% Quick Ratio0.70 Sales past 5Y1.70% Gross Margin69.40% 52W Low8.52% ATR0.65
Employees99451 Current Ratio1.00 Sales Q/Q-10.00% Oper. Margin24.30% RSI (14)52.00 Volatility0.84% 1.31%
OptionableYes Debt/Eq3.76 EPS Q/Q-58.70% Profit Margin17.60% Rel Volume0.88 Prev Close45.14
ShortableYes LT Debt/Eq2.70 EarningsFeb 03 Payout91.90% Avg Volume5.10M Price45.48
Recom2.50 SMA201.95% SMA50-1.66% SMA200-10.30% Volume2,299,446 Change0.75%
08-Aug-14Reiterated Argus Buy $65 → $55
23-Apr-14Upgrade Argus Hold → Buy
28-May-13Upgrade Deutsche Bank Hold → Buy
11-Jan-11Upgrade Jefferies Hold → Buy
02-Jun-10Upgrade Jefferies Hold → Buy
16-Feb-10Upgrade JP Morgan Underweight → Neutral $26
13-Jan-10Downgrade Credit Suisse Outperform → Underperform
24-Nov-09Initiated Leerink Swann Mkt Perform
16-Nov-09Initiated Deutsche Securities Hold
12-Nov-09Initiated Barclays Capital Equal Weight
23-Oct-09Downgrade Jefferies & Co Buy → Hold
17-Mar-09Initiated Credit Suisse Outperform
26-Jan-09Initiated Jefferies & Co Buy
14-Nov-08Downgrade UBS Buy → Neutral
18-Apr-08Downgrade JP Morgan Neutral → Underweight
11-Feb-08Upgrade UBS Neutral → Buy
01-Feb-08Upgrade HSBC Securities Underweight → Neutral
24-Oct-07Initiated Bernstein Mkt Perform
06-Sep-07Initiated UBS Neutral
25-Jul-07Downgrade Bear Stearns Peer Perform → Underperform
29-Oct-14 08:59AM  Dear Sanofi: Firing CEO Chris Viehbacher Is A Huge Mistake at Forbes
28-Oct-14 09:37PM  After merger, where's Walgreen Boots Alliance headed? CNBC
03:31PM  In Ebola Crisis, New Vaccine Candidates Show Uncertain Promise at Forbes
10:07AM  Ebola: The making of a $1 billion drug at CNNMoney.com
06:12AM  Novartis' precision M&A plan: CEO CNBC
27-Oct-14 06:48PM  The Ebola Crisis In 3 Charts And 3 Articles at Forbes
01:38PM  Will Novartis (NVS) Disappoint in Q3 Earnings Season? Zacks
26-Oct-14 02:59PM  Drugmakers bet on Ebola vaccines, treatments at USA TODAY
24-Oct-14 09:51AM  J&J and Glaxo Ready to Collaborate for Ebola Vaccine Work Zacks
08:35AM  Glaxo Gains on Q3 Earnings Beat and Restructuring Plans Zacks
23-Oct-14 11:44PM  Head of GSK Ebola Vaccine Research: "Can We Even Consider Doing A Trial?" at Forbes
01:38PM  Drugmakers want indemnity CNBC
12:51AM  [$$] GlaxoSmithKline Unveils Cost-Saving Plan, Considers IPO of HIV Business at The Wall Street Journal
22-Oct-14 04:30PM  Stocks Erase Gains to End Lower Morningstar
11:57AM  Alibaba bounces back, Six Flags riding high and Glaxo to tackle Ebola Yahoo Finance
11:30AM  Stocks Move Higher Again After Earnings Morningstar
10:23AM  Glaxo Considers ViiV IPO to Capitalize on HIV-Drug Sales at Bloomberg
09:38AM  Europe shares fluctuate on ECB rumors; BAT falls at CNBC
09:14AM  GlaxoSmithKline moving forward with Ebola vaccine at Fortune
08:46AM  Why GlaxoSmithKline (GSK) Stock Is Up Today at TheStreet
07:55AM  [$$] Glaxo Third-Quarter Earnings Beat Expectations at The Wall Street Journal
07:48AM  GSK CEO and CFO Interviewed on 2014 Q3 Results PR Newswire
07:22AM  GSK revenue disappoints with 3% fall to $8.9B at CNBC
07:16AM  Glaxo Third-Quarter Profit Beat Estimates at Bloomberg
05:00AM  Learn How To Invest Defensively From This Hedge Fund Pro at Investopedia
01:50AM  Testing for Ebola Vaccines to Start Soon, W.H.O. Says at New York Times
21-Oct-14 07:29PM  Earnings set to take markets' center stage at CNBC
03:17PM  Trading Ebola CNBC
01:31PM  Vaccines, Medical Oxygen, and Helping the Ebola Crisis Accesswire
11:26AM  Glaxo Rising Star Connelly Under Pressure as Drugs Falter at Bloomberg
20-Oct-14 05:15PM  Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? Zacks
09:00AM  ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S. PR Newswire
08:09AM  The Zacks Analyst Blog Highlights: GlaxoSmithKline, NewLink Genetics, Allergan, Inovio Pharmaceuticals and BioCryst Pharmaceuticals Zacks
18-Oct-14 12:12PM  U.K.s Glaxo Working to Accelerate Treatment for Ebola Virus at Bloomberg
17-Oct-14 04:50PM  Next week's earnings: Tech takes center stage CNBC
01:35PM  Healthcare Stocks in Focus on Ebola Fears Zacks
16-Oct-14 08:53AM  CDC needs to get ahead of Ebola: Cramer CNBC
15-Oct-14 10:00AM  Ebola: Is the world ready for the next pandemic? at CNBC
10-Oct-14 04:52PM  AstraZeneca's Benralizumab Encourages in Phase II Study Zacks
01:03PM  GSK, REGN And SHPG, 3 Drugs Stocks Pushing The Industry Lower at TheStreet
09-Oct-14 02:38PM  Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear at Investor's Business Daily
02:18AM  Glaxo Agrees to Take 25% Stake in Aspen Pharmacare Japanese Unit at Bloomberg
07-Oct-14 05:10PM  Teva to Concentrate on Core Specialty Therapeutics Zacks
01:36PM  Flu Drug Study Sees Ties Between Pharm Cos and Researchers' Positive Findings at The Wall Street Journal
12:16PM  Fast-tracking an Ebola vaccine may prove too slow at CNBC
09:15AM  Obama: US working on Ebola screening CNBC
09:15AM  [video] Obama: US working on Ebola screening at CNBC
08:01AM  Battling Ebola CNBC
07:16AM  How prepared is US to contain Ebola? CNBC
07:16AM  [video] How prepared is US to contain Ebola? at CNBC
06:01AM  Dallas Ebola patient to get experimental drug CNBC
06-Oct-14 02:41PM  First Ebola case contracted outside West Africa: Report CNBC
02:41PM  [video] First Ebola case contracted outside West Africa: Report at CNBC
02:00PM  Ebola patient gets Chimerix's drug CNBC
02:00PM  [video] Ebola patient gets Chimerix's drug at CNBC
10:13AM  Dallas patient with Ebola in critical condition CNBC
10:13AM  [video] Dallas patient with Ebola in critical condition at CNBC
04-Oct-14 10:00AM  [video] What You Need to Know About Female Whistleblowers in the Workplace at TheStreet
03-Oct-14 11:59AM  [$$] Credit Suisse Chairman Rohner to Join GlaxoSmithKline Board at The Wall Street Journal
11:50AM  Prosensa (RNA) Extends Re-Dosing of Drisapersen into Europe Zacks
07:03AM  CDC tracking contacts to Texas Ebola patient CNBC
01-Oct-14 04:17PM  Ebola vaccine: Why it's taking so long to make one at CNBC
03:04PM  Getting Ebola treatments to market may take time at MarketWatch
02:21PM  Ebola stocks: Who's leading? CNBC
02:21PM  [video] Ebola stocks: Who's leading? at CNBC
02:20PM  Ebola-Related Pharma Stocks Soar On First U.S. Case at Investor's Business Daily
09:15AM  Hot Action in Ebola-Related Stocks at Fox Business
08:14AM  Is Your Doctor Being Paid By Pharma? That Could Be Good. at Forbes
30-Sep-14 07:40PM  US won't see an Ebola epidemic: Expert CNBC
26-Sep-14 08:24PM  Ebola Shot Turned Down by WHO Is Best Hope as Virus Rages at Bloomberg
03:07PM  Biotech's future: The government is key Yahoo Finance
05:30AM  Ebola Shot Turned Down by WHO Is Now Best Hope Bloomberg
25-Sep-14 04:07PM  World Health Leaders' Response When Offered Ebola Vaccine: We'll Get Back to You Bloomberg
01:29PM  [video] Drug Firms Redirect Sales Pitch to Hospitals at MarketWatch
12:51PM  Ebola Shot Turned Down by WHO Is Best Hope as Virus Rages at Bloomberg
06:02AM  [$$] Glaxo Names Hampton Chairman at The Wall Street Journal
04:38AM  R.B.S. Chairman to Step Down at New York Times
03:01AM  Glaxo Names RBSs Hampton as Chairman, Replacing Gent at Bloomberg
24-Sep-14 07:01PM  Biotech Firm Adaptimmune Attracts $104 Million Investment at New York Times
05:29PM  Gilead's New HIV Drug Key To Long-Term Strategy at Investor's Business Daily
04:17PM  Why GlaxoSmithKline (GSK) Stock Rose Today at TheStreet
11:25AM  Glaxo Said Planning to Name RBSs Hampton as Chairman at Bloomberg
23-Sep-14 01:40PM  Ebola drug maker's stock soars at CNNMoney.com
22-Sep-14 04:45PM  Glaxo Fined Roughly $484M in China Bribery Probe Zacks
12:00PM  How Will GlaxoSmithKline (GSK) Stock React To Shareholder Skepticism? at TheStreet
09:30AM  China very important for world growth: Cramer CNBC
09:30AM  [video] China very important for world growth: Cramer at CNBC
08:25AM  Top Analyst Upgrades and Downgrades: Auxilium, BofA, Genworth, MGM, Walgreen, Wynn, Yahoo and More at 24/7 Wall St.
07:00AM  How Should Foreign Companies Interpret GSK's China Fines And Penalties? at Forbes
21-Sep-14 07:00PM  Glaxos China Fine Signals No Immunity for Multinationals at Bloomberg
20-Sep-14 04:58AM  [$$] GlaxoSmithKline Found Guilty of Bribery in China at The Wall Street Journal
19-Sep-14 05:18PM  [video] China Finds GlaxoSmithKline Guilty of Bribery, Delivers $490M Fine at TheStreet
05:16PM  China fines GlaxoSmithKline $492M for bribery AP
04:16PM  [video] Scottish Leader Salmond to Resign, and More at MarketWatch
02:28PM  [$$] Glaxo Guilty of Bribery in China at The Wall Street Journal
12:27PM  How Will GlaxoSmithKline (GSK) Stock Be Affected By This Lawsuit? at TheStreet
10:58AM  Glaxo Faces an Uphill Battle in China at The Wall Street Journal
10:20AM  Glaxo Found Guilty of Bribery in China: Can Witty Rehabilitate the Drug Maker? at The Wall Street Journal
06:37AM  What Alibaba means to China CNBC
06:37AM  [video] What Alibaba means to China at CNBC
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company's nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. The company has a strategic cancer immunotherapy collaboration with Adaptimmune Limited to develop and commercialize NY-ESO-1 clinical cancer program. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerAug 11Buy3912271.66172,651675,457,614,37130,748,723Aug 11 04:55 PM
GLAXOSMITHKLINE PLC10% OwnerMay 09Buy8544835.30317,7702,715,292,313,28130,576,072May 13 04:43 PM
GLAXOSMITHKLINE PLC10% OwnerApr 01Buy12.00103,7621,245,1441,989,598Apr 02 12:42 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerFeb 19Buy14.0035,000490,0001,356,533Feb 20 06:56 PM
GLAXOSMITHKLINE PLC10% OwnerFeb 11Buy12850698.95342,2294,397,881,850,96030,258,302Feb 13 04:41 PM
GLAXOSMITHKLINE PLCFormer 10% ShareholderFeb 10Buy12.00143,7731,725,276143,773Feb 12 05:56 PM